ABSTRA CT To evaluate the effects of parathyroid hormone and cyclic adenosine monophosphate on proximal tubular sodium and phosphate reabsorption, micropuncture studies were performed on dogs that received a highly purified preparation of parathyroid hormone (PTH), dibutyryl cyclic 3',5'-adenosine monophosphate (cyclic AMP), 5'-AMP, and saline. PTH resulted in a 30-40% inhibition of sodium and phosphate reabsorption in the proximal tubule unassociated with a rise in either total kidney or single nephron glomerular filtration rate (GFR). The bulk of the phosphate rejected proximally was excreted in the final urine while sodium excretion rose minimally despite the marked proximal inhibition, consistent with the presence of reabsorptive sites in the distal nephron for sodium but not phosphate. The infusion of dibutyryl cyclic AMP either systemically or directly into the renal artery inhibited proximal sodium and phosphate reabsorption in the absence of changes in either total kidney or single nephron GFR, resembling the effects of PTH quantitatively and qualitatively. In contrast, another adenine nucleotide, 5'-AMP, did not inhibit the reabsorption of either sodium or phosphate. These observations support the thesis that renal effects of PTH are mediated via stimulation of renal cortical adenyl cyclase. The infusion of a moderate saline load, 25 ml/kg, also produced a similar inhibition of proximal tubular fractional sodium and phosphate reabsorption with a marked phosphaturia but only minimal natriuresis. Thus, changes in An abstract of this work was published previously (1970. J. Clin. Invest. 49: 77a.).
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INTRODUCTION
The regulation of the renal excretion of phosphate is an incompletely understood subject. Stop-flow studies in the dog (1) and micropuncture studies in the rat (2) have indicated that the major site of phosphate reabsorption in the mammalian kidney is the proximal tubule. Although net tubular secretion of phosphate has been demonstrated in the chicken (3) and aglomerular fish (4) its occurrence in mammals has not been documented (5, 6) . Recent studies have demonstrated an inhibition of tubular phosphate reabsorption after extracellular fluid (ECF) expansion in the rat (7) , thyroparathyroidectomized dog (8, 9) , and normal man (10) . In addition, certain diuretics such as acetazolamide and furosemide, whose renal sites of action include the proximal tubule (11, 12) have been shown to be consistently phosphaturic (13) while others, which appear to possess a natriuretic action more limited to the distal nephron (14-16) do not increase phosphate excretion (13, 16) . The above observations suggest a relationship between sodium and phosphate reabsorption in the proximal tubule.
Parathyroid hormone (PTH) has for many years been considered a major factor in the regulation of phosphate excretion. The mechanism of its phosphaturic effect is probably related to an inhibitory action on tubular phosphate reabsorption (17, 18 ). An effect of PTH also upon urinary excretion of sodium has been periodically observed since 1935 (19) but, as many preparations of PTH have had variable effects on renal blood flow and GFR (20) , the physiological mechanism of the observed rise in sodium excretion and its relationship to the phosphaturia is unclear.
In recent years, evidence has accumulated to suggest that the phosphaturic effects of PTH may be mediated via stimulation of adenyl cyclase activity in tubular cells of the renal cortex causing an increase in intracellular cyclic adenosine 3',5'-monophosphate (cyclic AMP) (21) (22) (23) (24) (25) . Thus while cyclic AMP may mimic the phosphaturic effect of PTH (26) its influence on the tubular handling of sodium and the relationship between tubular transport of sodium and phosphate have not been defined.
This study was designed to investigate via micropuncture techniques, the relationships between sodium and phosphate reabsorption in the proximal tubule of the dog nephron as affected by a purified preparation of PTH, dibutyryl cyclic AMP, and moderate expansion of the ECF space with saline. The data reveal that all three of these experimental maneuvers inhibit both sodium and phosphate reabsorption similarly in the proximal tubule. The bulk of the sodium rejected proximally did not appear in the final urine which contained a major portion of the unreabsorbed phosphate. These studies are consistent with the thesis that phosphate reabsorption is closely related to proximal tubular sodium transport. Therefore, the phosphaturic action of PTH, via cyclic AMP, might be mediated by a direct inhibition of proximal sodium reabsorption.
METHODS
Mongrel dogs of either sex, weighing 15-20 kg, which had been fasted for 12 hr were anesthetized with sodium pentobarbital (20 mg/kg.). The animals were intubated and ventilated with a Harvard respirator pump. Cannulas were inserted into the left femoral vein for sustaining infusions and into the left femoral artery for blood sampling and blood pressure recording. Polyethylene cannules were placed into both ureters via a mid-line suprapubic incision for timed collections of urine. The left kidney was exposed through a subcostal incision and a catheter was inserted via the right femoral artery into the abdominal aorta to the level of the left renal artery for subsequent infusion of lissamine green. A priming dose of 200 mg/kg of inulin was given followed by a sustaining infusion in 0.9% saline at a rate of 1.0 ml/min. Parathyroid hormone. In eight dogs, following initial collections, a sufficient amount of a highly purified preparation of PTH, 740-1300 U/mg, (Wilson Laboratories, Chicago, Ill.) was added to the inulin-saline solution so as to deliver 50-60 U/hr. Recollection micropuncture samples were obtained 60-90 min after the initiation of the infusion, and two urine collections were obtained during this period.
Dibutyryl cyclic AMP. In six dogs dibutyryl cyclic AMP was added to the intravenous infusate to deliver 100 mg/hr at 1 ml/min. After obtaining the control micropuncture samples, recollections were obtained as described above. In eight dogs, a 23 gauge needle was inserted into the left renal artery, directed toward the aorta, and 0.9% normal saline at a rate of 0.1 ml/min was infused during the control periods. After completion of the control collections, sufficient dibutyryl cyclic AMP was added to this solution to allow infusion of either 0.014 mg/kg per hr (four dogs) or 0.75 mg/kg per hr (four dogs). Urine collections were obtained from both kidneys and recollection samples were obtained during the second hour of infusion.
Adenosine 5'-monophosphate (5'-AMP). In four dogs, after obtaining initial control samples, 5'-AMP was added to the inulin-saline infusion solution in amounts sufficient to deliver 100 mg/hr at a rate of 1 ml/min. Recollection micropuncture samples and two urine collection periods were obtained during the second hour of infusion.
Saline. After the control period, six dogs were expanded with 25 ml/kg of a solution containing 125 mEq/liter sodium, 20 mEq/liter bicarbonate, 109 mEq/liter chloride, 3.6 mEq/liter calcium, 4 mEq/liter potassium, infused at a rate of 20 ml/min. Following the initial expansion, urine losses of water and electrolytes were continuously replaced and recollection micropuncture samples and urine collections obtained in the second hour after completion of expansion.
After collection, tubular fluid samples were transferred under oil to quartz tubing and aliquots were removed for determination of inulin and phosphate. The volume of tubular fluid collected was then measured using constant bore quartz tubing of known inner diameter and a cathetometer. Inulin concentration was measured in duplicate in 6-nl aliquots using the fluorometric method of Vurek and Pegram (27) .
Tubular fluid phosphate concentrations were measured in duplicate using a modification of the ultra-micro method of Howell, Pita, Marquez, and Madruga (28) . 2 concentration range of 3-11 mg/100 ml was 100.9 ±2.3% using 25-nl samples.
Blood samples for calcium and phosphate, drawn anaerobically, were immediately placed under oil, allowed to clot, and centrifuged. 5 ml of serum was then transferred under oil to Centriflo membrane cones (Amicon Corp., Lexington, Mass.) and centrifuged at 2000 rpm for 30 min. Calcium in serum and ultrafiltrates was measured with a Perkin-Elmer Atomic Absorption Spectrophotometer and phosphate in serum and ultrafiltrates and urine were measured as previously described (13) . Sodium concentration in blood and urine samples was determined by flame photometry and inulin was determined with an AutoAnalyzer using a modification of previously described anthrone methods (30, 31) . and SNGFR for the experimental kidney in each dog were treated as single observations and compared with the mean values during the recollection period. The significance of the mean difference between control and experimental observations was determined by the t test for paired or nonindependent variables (32) . Parathyroid hormone. The effects of a systemic 'infusion of purified PTH, 50 60 U/hr, were studied in Table II and data illustrating a unilateral phosphaturia in all four dogs receiving this dose are depicted in Fig. 4 . Fractional phosphate excretion in the experimental kidney rose markedly after the initiation of the infusion. There was no change in GFR in either control or experimental kidneys and at a time when the phosphaturia was predominantly unilateral, (TF/P)in measured in 12 control recollection pairs of tubules in two dogs (one of which is represented in Table II) fell from 1.45 to 1.33 reflecting a fall in fractional sodium reabsorption from 0.31 to 0.23. These results agree closely with the micropuncture data for the entire group receiving the intra-arterial infusion as well as the group receiving intravenous dibutyryl cyclic AMP (Table I) .
RESULTS
Adenosine 5'-monophosphate. In order to study the specificity of the results obtained with dibutyryl cyclic AMP, another adenine nucleotide, 5'AMP, was infused systemically, 100 mg/hr, into four dogs (Fig. 5) . In one, separately identified in Fig. 5 , GFR fell by 60% associated with a marked rise in (TF/P)1. in the three tubules studied. In the other three dogs, in which the changes in GFR were less than 15%, the mean (TF/ P) In in 14 control recollection pairs of tubules of 1.55 ±0.05 during control and 1.55 +0.07 during recollection as shown in Fig. 5 were not significantly different. The results in Table I given animal was +5% and there was no significant alteration in either total or ultrafilterable calcium and phosphate associated with -the administration of PTH, saline, dibutyryl cyclic AMP, or 5'-AMP.
DISCUSSION
The data demonstrate that PTH and cyclic AMP inhibit both the absolute and fractional reabsorption of phosphate and sodium in the proximal tubule. In none of the experiments did the data suggest net tubular secretion of phosphate. In the final urine, these agents are associated with a marked increase in the excretion of phosphate and only a small increase in sodium excretion despite the marked proximal inhibition. Previous micro- puncture studies in the rat (2) and stop-flow studies in the dog (1) (21) and man (23) and a selective stimulation of renal cortical adenyl cyclase in the rat (24) and rabbit (22) . The site of stimulation of cortical adenyl cyclase has recently been more precisely localized to the cortical tubule (25) . In addition, systemic infusion of dibutyryl cyclic AMP has resulted in increased phosphate excretion in both the rat (26) and dog (33) . In our studies, the physiological effects of PTH and dibutyryl cyclic AMP both in the proximal tubule and in the final urine were indistinguishable, while 5'-AMP had no inhibitory effect in the proximal tubule. The (13) and acetazolamide (13) , and after extracellular fluid volume expansion (7) (8) (9) (10) ). Another feature common to these agents is depression of proximal tubular fractional sodium reabsorption (11, 12, 34) . In contrast, other diuretics such as the thiazides, ethacrynic acid, triflocin, and mannitol with natriuretic sites of action more limited to the distal nephron (14) (15) (16) 35) do not consistently increase phosphate excretion (13, 16) . In our studies, PTH, an agent previously thought to be specifically phosphaturic, effected an inhibition of proximal tubular sodium transport of 32% equivalent to that produced by the saline loading experiments. These data suggest that sodium and phosphate transport in the proximal tubule might be intimately related. The mean (TF/UF)p in the proximal tubule in the control animals was approximately 0.7, similar to that observed by others in the rat (2) , and rose after the administration of PTH, dibutyryl cyclic AMP, and saline. As sodium reabsorption in the proximal tubule is isosmotic, the sodium/phosphate ratio was lower in the reabsorbate than in the filtrate where the molar ratio is 140/1. In our studies, at a point in the proximal tubule where approximately 30% of filtered sodium had been reabsorbed, 42% of filtered phosphate was reabsorbed. Thus, each mmole of phosphate in the reabsorbate was associated with approximately 100 mmoles of sodium. If the inhibition of proximal sodium reabsorption due to PTH and cyclic AMP were merely a consequence of a primary effect of these agents on phosphate, and secondarily, a passive ionic association of sodium with phosphate as Na2HPO4 or NaH2PO4, then one would expect a sodium/phosphate molar ratio in the rejectate no greater than 2/1. A rough calculation of our data based on SNGFR, (TF/P)1i, and (TF/ UF)p indicates a sodium/phosphate molar ratio in proximal tubular rejectate following these agents of approximately 75/1. Based upon these data and studies by others discussed above, we propose that proximal tubular reabsorption of phosphate might be dependent upon the tubular reabsorption of sodium. Accordingly, factors which enhance phosphate excretion would do so by primarily inhibiting proximal tubular sodium transport. Unless there is a simultaneous distal inhibitory effect on sodium this proximal action would result in a phosphaturia with little or no natriuresis. The data as reported here, however, do not conclusively prove the existence of such a relationship and further studies under a variety of experimental conditions are required. The precise nature of the proposed linkage between sodium and phosphate reabsorption is not clear from our data. A simple solvent drag phenomenon cannot be invoked since this mechanism cannot account for a phosphate concentration in the reabsorbate higher than in tubular fluid. The observed (TF/UF)p of 0.7 is compatible with passive distribution of phosphate at electrochemical equilibrium according to the Nernst equation, assuming the existence of a small transtubular potential difference of -4 mv in the dog proximal tubule (36) .
Such calculations are, of course, subject to multiple criticisms and do not prove the passive nature of phosphate reabsorption. Carrier-mediated phosphate transport could be linked to sodium by a double-ion carrier, perhaps similar to that proposed by Diamond in the gall bladder (37) . Further more direct studies are required to evaluate these possibilities.
